Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The vaginal ecological niche is a complex biological environment defined by the interaction between the host vaginal epithelium, the local immune system, and a specialized community of microorganisms known as the vaginal microbiota. In healthy women of reproductive age, this niche is typically dominated by Lactobacillus species, which play a critical role in maintaining a low pH (3.5–4.5) through the fermentation of glycogen-derived products into lactic acid (Ravel et al., 2011, PNAS). This acidic environment, supplemented by the production of antimicrobial compounds like hydrogen peroxide and bacteriocins, serves as a primary defense against the colonization of pathogenic organisms (Borges et al., 2014, Arch Gynecol Obstet). Disruption of this ecological balance, often termed dysbiosis, can lead to conditions such as bacterial vaginosis (BV) and increased susceptibility to sexually transmitted infections (STIs) and aerobic vaginitis (Coudray & Madhivanan, 2020, Sex Transm Dis). Therapeutic strategies targeting the vaginal niche include the use of antibiotics to eliminate overgrowing anaerobes, as well as the administration of probiotics or live biotherapeutic products (LBPs) to restore beneficial Lactobacillus populations (Cohen et al., 2020, NEJM). Monitoring the health of this niche often involves assessing biomarkers such as vaginal pH, the Nugent score, and the relative abundance of specific microbial taxa (Petrova et al., 2015, Front Physiol).
Restoration of commensal microbial populations, acidification of the vaginal environment, competitive inhibition of pathogens, and modulation of the local mucosal immune response.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vaginal ecological niche.